MX2018015725A - Método para facilitar la maduración del sistema inmunitario de mamíferos. - Google Patents

Método para facilitar la maduración del sistema inmunitario de mamíferos.

Info

Publication number
MX2018015725A
MX2018015725A MX2018015725A MX2018015725A MX2018015725A MX 2018015725 A MX2018015725 A MX 2018015725A MX 2018015725 A MX2018015725 A MX 2018015725A MX 2018015725 A MX2018015725 A MX 2018015725A MX 2018015725 A MX2018015725 A MX 2018015725A
Authority
MX
Mexico
Prior art keywords
immune system
mammalian immune
growth
compositions
milk oligosaccharides
Prior art date
Application number
MX2018015725A
Other languages
English (en)
Inventor
Frese Steven
Kyle David
FREEMAN-SHARKEY Samara
Henrick Bethany
Original Assignee
Evolve Biosystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evolve Biosystems Inc filed Critical Evolve Biosystems Inc
Publication of MX2018015725A publication Critical patent/MX2018015725A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/152Milk preparations; Milk powder or milk powder preparations containing additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/10Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/163Sugars; Polysaccharides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/51Bifidobacterium
    • A23V2400/529Infantis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/51Bifidobacterium
    • A23V2400/533Longum
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • C12R2001/23Lactobacillus acidophilus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • C12R2001/24Lactobacillus brevis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • C12R2001/245Lactobacillus casei
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • C12R2001/25Lactobacillus plantarum
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Husbandry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Pediatric Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Las invenciones descritas en la presente hacen referencia, en líneas generales, al uso de composiciones para aumentar la producción de acetato y lactato, y simultáneamente reducir el pH y los niveles de bacterias patogénicas y la inflamación intestinal de un mamífero bebé lactante que incluye seres humanos. En general, estas composiciones comprenden una o más cepas bacterianas seleccionadas por su crecimiento en oligosacáridos de la leche de mamíferos, una fuente de oligosacáridos de leche de mamíferos y, opcionalmente, componentes nutritivos necesarios para el crecimiento del mamífero bebé.
MX2018015725A 2016-07-01 2017-06-30 Método para facilitar la maduración del sistema inmunitario de mamíferos. MX2018015725A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662357820P 2016-07-01 2016-07-01
US201662397788P 2016-09-21 2016-09-21
PCT/US2017/040530 WO2018006080A1 (en) 2016-07-01 2017-06-30 Method for facilitating maturation of the mammalian immune system

Publications (1)

Publication Number Publication Date
MX2018015725A true MX2018015725A (es) 2019-09-09

Family

ID=60785488

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018015725A MX2018015725A (es) 2016-07-01 2017-06-30 Método para facilitar la maduración del sistema inmunitario de mamíferos.
MX2022009575A MX2022009575A (es) 2016-07-01 2018-12-14 Una composicion que comprende bacteria y/o oligosacaridos de la leche de mamiferos (mmo) para usarse en el tratamiento y mantenimiento de la salud de un mamifero.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2022009575A MX2022009575A (es) 2016-07-01 2018-12-14 Una composicion que comprende bacteria y/o oligosacaridos de la leche de mamiferos (mmo) para usarse en el tratamiento y mantenimiento de la salud de un mamifero.

Country Status (9)

Country Link
US (2) US11318175B2 (es)
EP (1) EP3478093A4 (es)
CN (2) CN117385064A (es)
AU (2) AU2017290900A1 (es)
BR (1) BR112018076927A2 (es)
CA (1) CA3029631A1 (es)
MX (2) MX2018015725A (es)
SG (1) SG11201811227QA (es)
WO (1) WO2018006080A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY180910A (en) 2010-12-31 2020-12-11 Abbott Lab Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
SG10202110501RA (en) 2010-12-31 2021-11-29 Abbott Lab Methods For Decreasing The Incidence Of Necrotizing Enterocolitis In Infants, Toddlers, Or Children Using Human Milk Oligosaccharides
ES2657744T3 (es) 2011-07-22 2018-03-06 Abbott Laboratories Galactoligosacáridos para prevenir lesiones y/o promover la curación del tracto gastrointestinal
US10639319B2 (en) 2011-08-29 2020-05-05 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
WO2018041803A1 (en) * 2016-08-31 2018-03-08 Prismagen Gmbh Use of human milk oligosaccharides in calves fattening
US11524019B2 (en) 2017-08-21 2022-12-13 Glycom A/S Synthetic composition for reducing allergy symptoms
CN111587376A (zh) * 2017-09-13 2020-08-25 进化生物系统股份有限公司 哺乳动物婴儿的代谢组学修正
EP3735130A4 (en) * 2018-01-03 2022-02-16 Evolve Biosystems, Inc. METHOD FOR DETERMINING DYSBIosis IN THE INTESTINAL MICROBIOME
WO2019143871A1 (en) * 2018-01-17 2019-07-25 Evolve Biosystems, Inc. Activation of conditionally-expressed oligosaccharide pathways during fermentation of probiotic strains
KR20210016557A (ko) 2018-05-31 2021-02-16 글리콤 에이/에스 자가면역 질환 치료를 위한 hmo 혼합물
GB201900744D0 (en) 2019-01-18 2019-03-06 Mars Inc Monitoring tools and diagnostic methods
GB201900745D0 (en) 2019-01-18 2019-03-06 Mars Inc Monitoring tools and diagnostic methods
GB201900750D0 (en) 2019-01-18 2019-03-06 Mars Inc Monitoring tools and diagnostic methods
GB201900754D0 (en) 2019-01-18 2019-03-06 Mars Inc Monitoring tools and diagnostic methods
GB201914385D0 (en) 2019-10-04 2019-11-20 Mars Inc Microbiome Interventions
CN112870232A (zh) * 2019-11-29 2021-06-01 内蒙古伊利实业集团股份有限公司 乳双歧杆菌bl-99提升肠道细菌感染抗性和肠道免疫力的应用
CA3179561A1 (en) * 2020-04-08 2021-10-14 Megmilk Snow Brand Co., Ltd. Composition for improving gut microbiota
BG67567B1 (bg) * 2020-05-27 2023-09-15 Гама Консулт-Калинкин, Прокопов И С-Ие Сд Метод за количествена оценка за бързо прогнозиране и контрол на дисбиози при кърмачета на възраст от един месец до една година
JP2024514745A (ja) * 2021-02-22 2024-04-03 テイト アンド ライル ソリューションズ ユー・エス・エー エル・エル・シー ラクトバチルス・ムコサエと可溶性食物繊維との組み合わせを用いた方法および組成物
EP4094590A1 (en) * 2021-05-27 2022-11-30 Tate & Lyle Solutions USA LLC Methods and compositions using combinations of lactobacillus mucosae and soluble dietary fiber

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
EP1920782A1 (en) * 2006-11-10 2008-05-14 Glycotope Gmbh Carboyhdrate specific cellular immunity inducing microorganisms and fractions thereof
CA2760999A1 (en) * 2009-03-13 2010-09-16 Mariana Barboza Prebiotic oligosaccharides
US20110066700A1 (en) * 2009-09-15 2011-03-17 Jackson Chao Behavior monitoring system
CN103402376A (zh) * 2010-12-31 2013-11-20 雅培制药有限公司 促进有益细菌生长的中性人乳寡糖
SG10202110501RA (en) * 2010-12-31 2021-11-29 Abbott Lab Methods For Decreasing The Incidence Of Necrotizing Enterocolitis In Infants, Toddlers, Or Children Using Human Milk Oligosaccharides
WO2012092155A1 (en) 2010-12-31 2012-07-05 Abbott Laboratories Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
MX2014012362A (es) 2012-04-13 2015-05-07 Trustees Boston College Composición prebiótica y métodos de uso.
WO2014121304A1 (en) 2013-02-04 2014-08-07 Seres Health, Inc. Compositions and methods
WO2014201037A2 (en) 2013-06-10 2014-12-18 New York University Methods for manipulating immune responses by altering microbiota
US9956282B2 (en) * 2013-12-16 2018-05-01 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
CN114376234A (zh) * 2014-10-24 2022-04-22 进化生物系统股份有限公司 活化的双歧杆菌及其应用方法
KR102606971B1 (ko) 2014-10-29 2023-11-30 바이오가이아 에이비 생애 초기에 미생물총 불균형을 회복하기 위한 l. 루테리의 용도
EP3229595B1 (en) * 2014-12-12 2021-02-03 The Regents of the University of California Reduction of milk glycans and their degradation products in the neonate gut
WO2016105513A1 (en) * 2014-12-23 2016-06-30 Evolve Biosystems Inc. Method for the noninvasive detection of activated bifidobacteria
WO2016141454A1 (en) * 2015-03-12 2016-09-15 The University Of British Columbia Bacterial compositions and methods of use thereof
US20190216861A1 (en) * 2015-09-22 2019-07-18 Mayo Foundation For Medical Education And Research Methods and materials for using biomarkers which predict susceptibility to clostridium difficile infection
CN105166914A (zh) * 2015-10-27 2015-12-23 江西美庐乳业集团有限公司 一种能调节肠道微生态环境,提升宝宝抗病能力、改善腹泻的营养包
WO2017084673A1 (en) 2015-11-17 2017-05-26 Glycom A/S Synthetic Composition for Treating Antibiotic Associated Complications

Also Published As

Publication number Publication date
MX2022009575A (es) 2022-09-09
WO2018006080A1 (en) 2018-01-04
EP3478093A1 (en) 2019-05-08
BR112018076927A2 (pt) 2019-04-02
US11318175B2 (en) 2022-05-03
US20220313759A1 (en) 2022-10-06
SG11201811227QA (en) 2019-01-30
CA3029631A1 (en) 2018-01-04
CN109475169A (zh) 2019-03-15
US20190224254A1 (en) 2019-07-25
AU2017290900A1 (en) 2019-01-17
EP3478093A4 (en) 2020-03-04
AU2023204422A1 (en) 2023-08-03
CN117385064A (zh) 2024-01-12

Similar Documents

Publication Publication Date Title
MX2022009575A (es) Una composicion que comprende bacteria y/o oligosacaridos de la leche de mamiferos (mmo) para usarse en el tratamiento y mantenimiento de la salud de un mamifero.
BR112017027640A2 (pt) leite fermentado inoculado com ambas bactérias ácido-láticas (lab) e bacilo
MX350325B (es) Bacteria para usarse como un probiotico para aplicaciones nutricionales y medicas.
NZ729306A (en) Bacillus amyloliquefaciens probiotic compositions, methods of production, and methods of use
MX354047B (es) Cepas/celulas de lactobacillus secadas por aspersion, y el uso de las mismas contra helicobacter pylori.
AR101545A1 (es) Método para producir un producto lácteo fermentado con baja concentración de lactosa
PH12017500708A1 (en) Probiotic and prebiotic compositions
WO2018231992A3 (en) METHODS OF USING LACTOBACILLUS PLANTARUM STRAINS TO PROTECT ANIMALS AGAINST PATHOGENIC BACTERIAL INFECTION
NZ706636A (en) Probiotic and prebiotic compositions
EP3554521A4 (en) ORAL LACTIC ACID BACTERIA COMPOSITION FOR THE REGULATION OF IMMUNE REACTIONS AND RELATED PROCEDURES
EP3787668C0 (en) PROBIOTIC BACTERIAL STRAINS THAT PRODUCE ANTIMICROBIAL PROTEINS AND COMPOSITIONS THEREOF FOR THE TREATMENT OF A CLOSTRIDIUM DIFFICILE INFECTION
AR095877A1 (es) Método para mejorar la calidad de la leche en animales productores de leche
BR112018003474A2 (pt) bactérias lactobacillus fermentum que reduzem a concentração de acetaldeído
MX2019015306A (es) Probioticos y metodos de uso.
WO2018232275A3 (en) ANTIMICROBIAL TREATMENT OF CARCASSES OF ANIMALS AND FOOD PRODUCTS
PH12020550651A1 (en) Gender specific synthetic nutritional compositions comprising lycopene and nutritional systems comprising them
MX2019010730A (es) Suplemento de proteina liquida esterilizada.
EA202190286A1 (ru) Микробиологический способ получения перги
MX2017007969A (es) Bacterias de acido lactico y su uso para el tratamiento de mastitis.
SG10201908193PA (en) Nucleotide composition and application in food thereof
MX2021012952A (es) Vacuna klebsiella y metodos de uso.
MX2018014532A (es) Un metodo para reducir la contaminacion de los huevos.
MX2020004347A (es) Preparacion de productos lacteos fermentados para distribucion ambiental.
PH12018500164A1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
PH12018500165A1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them